To further study the oncogenic roles of the new JAK3-INSL3 fusion transcript in CTCL, we examined the expression of the JAK3-INSL3 fusion transcript as well as wild type JAK3 in 10 CTCL cell lines. The gene discussed is JAK3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.